Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04057768 · ClinicalTrials.gov registry record · NA

Fractional Radiofrequency for the Treatment and Reduction of Acne Scars and Wrinkles

A NA study of Wrinkle and Acne Scars - Mixed Atrophic and Hypertrophic, sponsored by Venus Concept.

Completed
Registry status
NA
Development phase
10
Enrollment target
1
Study location

NCT04057768 is a NA study of Wrinkle and Acne Scars - Mixed Atrophic and Hypertrophic that has completed, run by Venus Concept. The registered enrollment target is 10 participants, below the 120-participant average among 25 other Wrinkle trials with a reported enrollment target (92% lower). The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04057768, a NA study of Wrinkle and Acne Scars - Mixed Atrophic and Hypertrophic, has completed, sponsored by Venus Concept.

COMPLETED
Registry status
NA
Development phase
10 participants
Enrollment target
1
Study location

Study Summary

The objective of this clinical study is to evaluate the efficacy of fractional RF for the treatment and reduction of acne scarring or facial wrinkles.

Interventions

  • DEVICE Venus Viva

Study Locations (1)

California

  • Laser and Skin Surgery Center of Northern California - Sacramento

Trial Details

FieldValue
Enrollment Target 10 participants
Start Date 2019-08-19
Est. Completion 2020-03-03
Phase NA

Sponsor

Venus Concept

22 total trials

What the Registry Record Tells You About NCT04057768

The ClinicalTrials.gov registry entry for NCT04057768 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 120-participant average among 25 other Wrinkle trials with a reported enrollment target (92% lower). The listed sponsor is Venus Concept, which has 22 total studies on file at ClinicalTrials.gov.

The record links to 2 conditions, with Wrinkle appearing as the primary indexed condition, and to 1 intervention - of which Venus Viva is the first listed.

NCT04057768 reports 1 study location spanning 1 distinct geographic area - top geographies include California.

Frequently Asked Questions

What is clinical trial NCT04057768 about?

NCT04057768 is a clinical study titled "Fractional Radiofrequency for the Treatment and Reduction of Acne Scars and Wrinkles". The objective of this clinical study is to evaluate the efficacy of fractional RF for the treatment and reduction of acne scarring or facial wrinkles.

What is the current status of trial NCT04057768?

This trial is currently completed. It is a NA study. The enrollment target is 10 participants. The study started on 2019-08-19. Estimated completion is 2020-03-03.

What conditions does trial NCT04057768 study?

This clinical trial studies the following conditions: Wrinkle, Acne Scars - Mixed Atrophic and Hypertrophic.

What interventions are being tested in trial NCT04057768?

The interventions under investigation include: Venus Viva (DEVICE).

Who is sponsoring clinical trial NCT04057768?

This trial is sponsored by Venus Concept, which has 22 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04057768 being conducted?

This trial has 1 study location across California. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Wrinkle

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.